Cyclophosphamide

Esordio di lupus eritematoso sistemico con sindrome da attivazione macrofagica, nefrite lupica e microangiopatia trombotica

G. Prunotto, V. Decimi, M.L. Melzi, M.A. Pelagatti, F. Ferrario, A. Biondi

2016/6

Trattamento della sindrome nefrosica idiopatica corticosensibile

C. Romanello

2005/9 — pag. 580-586

The steroid treatment of Idiopathic Nephrotic Syndrome (ISN) should be continued for at least 3 months, as there is evidence of an inverse correlation between the duration and the total dosage of steroids and the risk of relapses. The tendency to r...

Il rituximab nella cura dei pazienti con artrite reumatoide

G. Bartolozzi

2004/8

Una malattia rara, ma da non dimenticare…

I. Bruno

2002/2

Piastrinopenia cronica multiresistente in bambina con sindrome linfoproliferativa autoimmune (ALPS). Efficacia della ciclofosfamide

E. Barth, M. Rabusin G.A. Zanazzo, P. Tamaro

2001/8

Piastrinopenia cronica multiresistente in bambina con sindrome linfoproliferativa autoimmune (ALPS): efficacia della ciclofosfamide

E. Barth, M. Rabusin, GA. Zanazzo, P. Tamaro

2001/8 — pag. 548-548

Report of a very severe case of thrombocytopenia with lymphoproliferative autoimmune syndrome (hereditary ALPS) resistant to classical treatments, both in high doses or bolus, with prompt and durable response to cyclophosfamide....